ShikenPASSのALS-Con-201試験参考書はあなたを一回で試験に合格させるだけでなく、ALS-Con-201認定試験に関連する多くの知識を勉強させることもできます。ShikenPASSの問題集はあなたが身に付けるべき技能をすべて含んでいます。そうすると、あなたは自分自身の能力をよく高めることができ、仕事でよりよくそれらを適用することができます。ShikenPASS的ALS-Con-201問題集は絶対あなたがよく試験に準備して、しかも自分を向上させる一番良い選択です。ShikenPASSがあなたに美しい未来を与えることができることを信じてください。
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant |
| Exam Number: | ALS-Con-201 |
| Passing Score: | 62% |
| Related Certifications: | Salesforce Certified Platform Administrator |
| Available Languages: | English |
| Exam Format: | Multiple-choice, Scenario-based |
| Exam Price: | US$200 |
| Certificate Validity Period: | 2 years |
| Real Exam Qty: | 60-65 |
| Exam Duration: | 105 minutes |
| Recommended Training: | Agentforce Life Sciences Consultant Certification Preparation |
| Exam Registration: | Salesforce Certification Registration |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored or onsite testing center |
| Pre Condition: | Hold Salesforce Certified Platform Administrator certification; at least 1 year experience in life sciences industry; at least 6 months hands-on experience configuring Agentforce Life Sciences |
| Official Syllabus URL: | https://help.salesforce.com/s/articleView?id=005305357&language=en_US |
調査、研究を経って、IT職員の月給の増加とジョブのプロモーションはSalesforce ALS-Con-201資格認定と密接な関係があります。給料の増加とジョブのプロモーションを真になるために、ShikenPASSのSalesforce ALS-Con-201問題集を勉強しましょう。いつまでもALS-Con-201試験に準備する皆様に便宜を与えるShikenPASSは、高品質の試験資料と行き届いたサービスを提供します。
| トピック | 出題範囲 |
|---|---|
| トピック 1 |
|
| トピック 2 |
|
| トピック 3 |
|
| トピック 4 |
|
質問 # 96
Choose 1 option.
Cumulus Pharma notices that synchronization transactions have failed, impacting sales users' ability to view recently created records offline in the Agentforce Life Sciences mobile app.
What should an Agentforce Life Sciences Consultant recommend to identify potential synchronization transaction failures?
正解：C
解説：
Option C is correct. Salesforce Life Sciences Cloud documentation for Synchronization Management describes Simulation Mode as the feature used to proactively find and fix synchronization problems before they affect users. This is directly aligned with the question's wording: the consultant must identify potential synchronization transaction failures that could prevent recently created records from being available offline in the Life Sciences mobile app. Simulation Mode helps admins validate synchronization behavior in advance, rather than waiting for sales users to encounter missing or failed offline records.
Option B is not the best answer, even though the question included it as the proposed answer. Event Monitoring can be useful for broader Salesforce activity monitoring, but the Salesforce Life Sciences synchronization documentation points specifically to Synchronization Management and Simulation Mode for identifying and resolving sync problems in the Life Sciences mobile app context. Option A is also incorrect because sending warning emails to sales users would notify people after a problem or warning occurs; it does not test synchronization transactions or identify potential failures before users are impacted.
Therefore, to identify potential synchronization transaction failures and reduce offline data issues for field sales users, the consultant should leverage Simulation Mode to test transactions.
=========
質問 # 97
Choose 1 option.
Cumulus Pharma wants to ensure that whenever a field sales rep discusses a product during a visit, for example "Immunexis," the rep is required to record product-specific information before being allowed to submit the visit.
How should the Agentforce Life Sciences Consultant configure this requirement?
正解：B
解説：
Option C is correct because the requirement is product-specific and should be configured through Product Discussion Settings, not through a generic page-layout or Visit validation rule. Salesforce's Life Sciences Cloud Visit Management data model includes Provider Visit Product Discussion as the object that represents products discussed during a visit, including key details about the product brand, therapeutic area, and related information. Salesforce also documents ProviderVisitProdDiscussion as representing additional notes or information about products discussed during a healthcare provider visit.
The question asks for a configuration that applies when a specific product, such as Immunexis, is discussed. Enabling Require Discussion in Product Discussion Settings for the product record is the most targeted standard configuration because it ties the requirement to that product's visit discussion behavior.
Option A is not the best answer because a custom validation rule on Visit would have to inspect related product-discussion records and could become complex or unreliable for mobile visit submission behavior. Option B is also insufficient because making a Comments field required on the page layout would apply based on the layout, not specifically when Immunexis is discussed. It also would not necessarily enforce product-specific discussion requirements across all relevant visit submission paths. Therefore, the consultant should enable Require Discussion in Product Discussion Settings for the Immunexis product record.
=========
質問 # 98
Choose 1 option.
A field sales rep has logged personal time off for next Friday. However, they accidentally attempt to schedule a provider visit with a Healthcare Provider (HCP) during that same time slot. The system needs to prevent this action. The solution must use the standard Time Off Territory (TOT) configuration to enforce this restriction as a hard stop.
Which configuration should an Agentforce Life Sciences Consultant verify in the Visit/Calendar settings?
正解：B
解説：
Option B is correct because the requirement is specifically to prevent visit creation when a Visit overlaps with a Time Off Territory record. Salesforce Life Sciences documentation references Time Off Territory overlapping rules as the standard mechanism that prevents creating visits during TOT events. Salesforce's Winter '26 Customer Engagement package patch notes also mention an issue where a visit could be created during a Time Off Territory event, bypassing the overlapping rule that should have prevented creation. That confirms TOT overlapping rules are the expected standard control for this scenario.
Because the business wants a hard stop, the overlapping rule behavior must be set to "Error." This means the rep receives an error and cannot proceed with scheduling the visit while it conflicts with the TOT time block.
Option A is incorrect because a custom validation rule on Visit would duplicate a standard Life Sciences calendar/TOT capability and may not handle the full mobile scheduling experience correctly. Option C is also not the best answer because "Block Activity on Conflict" on the TOT record type is not the documented standard configuration in the Life Sciences Visit/Calendar settings. The correct standard configuration is to use TOT Overlapping Rules and set the overlap behavior to Error. This prevents scheduling visits during the rep's logged time off.
=========
質問 # 99
Choose 1 option.
An Agentforce Life Sciences Consultant needs to configure sample management rules. They must specify which types of Healthcare Organizations (HCOs) are eligible to receive samples and enforce that users must enter a batch number for every sample dropped.
Which subsection of Visit Settings should the consultant use for these configurations?
正解：C
解説：
The correct answer is C because the requirement is about sampling eligibility and validation behavior during visits. Salesforce Life Sciences sample management features support compliant handling and distribution of samples, and visit-related sample behavior is configured through visit settings and sample management setup. Salesforce Help describes sample management as enabling pharmaceutical companies to efficiently handle and distribute drug samples to providers, while the broader Customer Engagement setup includes Life Sciences mobile and visit configuration areas where these rules are applied.
The scenario includes two validation-style requirements. First, the consultant must specify which types of HCOs are eligible to receive samples. Second, the system must require users to enter a batch number for every sample drop. Both requirements are about enforcing rules during the sampling process, not about presenting product details or general sample item display.
Option A, Product Detailing Settings, is incorrect because product detailing is used to configure how products are discussed or presented during an engagement. It does not control HCO sample eligibility or mandatory batch entry. Option B, Samples and Items Settings, sounds related to sample availability, but the requirement is specifically about compliance validation. Option C, Sample and Validation Settings, is the correct subsection because it governs sample-related validation behavior, including eligibility and required information such as batch number entry. Therefore, the consultant should use Sample and Validation Settings.
=========
質問 # 100
Choose 1 option.
An Agentforce Life Sciences Consultant has configured the Medical Inquiry process for Cumulus Pharma. When a field sales rep submits a signed inquiry, the status correctly updates to "Submitted," but the Case record remains owned by the rep instead of being automatically routed to the Medical Science Liaisons (MSLs).
Which trigger handler is inactive?
正解：B
解説：
The correct answer is A because the symptom is specifically about Case ownership not changing after a Medical Inquiry is submitted. Salesforce Help for Medical Inquiries shows that the inquiry workflow uses Case status values such as Draft, Signed, Submitted, and Assigned, and Life Sciences Cloud also provides Trigger Handler Administration for configuring Life Sciences trigger handlers, including trigger handlers related to Case objects.
In the scenario, the status update is working correctly: the signed inquiry becomes Submitted. That means the submission process itself is functioning. The failure is isolated to ownership routing: the Case remains owned by the field sales rep instead of being routed to the Medical Science Liaison team or queue. Based on the available options, CaseChangeOwnershipHandler is the handler that directly corresponds to changing ownership on the Case record.
Option B, MSLInquirySubmissionHandler, sounds related to Medical Inquiry submission, but the submission status already updates correctly, so that is unlikely to be the inactive piece. Option C, CaseMSLQueueHandler, sounds like queue routing, but the Salesforce-style handler name that most directly describes the failed behavior is CaseChangeOwnershipHandler. Since the issue is ownership transfer after submission, the inactive trigger handler is CaseChangeOwnershipHandler.
=========
質問 # 101
......
ALS-Con-201受験記対策: https://www.shikenpass.com/ALS-Con-201-shiken.html